eye［J］.FASEB J 1988;2∶3017-3023.

　　［10］Ferguson TA,Fletcher S,Herndon JM,et al. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye［J］.J Immunol 1995;155∶1746-1756.

　　［11］Streilein JW.Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments［J］.Curr Opinion Immunol 1993;5∶432-482.

　　［12］McMenamin PG.Immunocompetent cells in the anterior segment［J］.Prog Reti Eye Res 1994;13∶555-591.

　　［13］Kaiser C,Ksander B,streilein JW.Inhibition of lymphocyte proliferation by aqueous humor［J］.Reg Immunol 1989;2∶42-49.

　　［14］Taylor AW,Yee DG,Streilein JW.Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor［J］.Invest Ophthalmol Vis Sci 1998;39∶1372-1378.

　　［15］Cousins SW,McCabe MM,Danielpour D,et al.Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor［J］.Invest Ophthalmol Vis Sci 1991;32∶33-43.

　　［16］Granstein R,Staszewski R,Knisely TL,et al.Aqueous humor contains transforming growth factor-β and a small inhibitor of thymocyte proliferation［J］.J Immunol 1990;144∶3021-3026.

　　［17］Takeuchi M,Alard P,Streilein JW.TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells［J］.J Immunol 1998;160∶1589-1597.

　　［18］Takeuchi M,Kosiewicz MM,Alard P,et al. On the mechanisms by which TGF-β alters antigen presenting abilities of macrophages on T cell activation［J］.Eur J Immunol 1997;27∶1648-1656.

上一页  [1] [2] [3] [4] [5] [6] [7] [8] [9] 下一页